Combined liver-kidney transplantation in an HIV-HCV-coinfected patient with haemophilia

AIDS

Volumn 22, Issue 15, 2008, Pages 2047-2049

  Ballarin, Roberto ^a,b   Di Benedetto, Fabrizio ^a   Masetti, Michele ^a   Spaggiari, Mario ^a   De Ruvo, Nicola ^a   Montalti, Roberto ^a   Romano, Antonio ^a   Cocchi, Stefania ^b   Guaraldi, Giovanni ^b   Gerunda, Giorgio E ^a  

^a Liver and Multivisceral Transplant Center   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; BASILIXIMAB; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CYCLOSPORIN; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISOLONE; RAPAMYCIN;

ADULT; BILE DUCT FISTULA; BLOOD TRANSFUSION; CASE REPORT; COMORBIDITY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEMOPHILIA A; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LIVER DYSFUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MIXED INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; HEMOPHILIA A; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PERIOPERATIVE CARE;

EID: 53549108862     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32830f4c8d     Document Type: Letter

References (13)

1. Darby SC, Kan SW, Spooner RJ, Giangrande PL, Lee CA, Makris M, et al. The impact of HIV on mortality rates in the complete UK haemophilia population. AIDS 2004; 18:525-533.
2. Wilde JT. HIV and HCV coinfection in haemophilia. Haemophilia 2004; 10:1-8.
3. Kuo PC, Stock PC Transplantation in the HIV+ patient. Am J Transplant 2001; 1:13-17.
4. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J AIDS 1993; 6:602-610.
5. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994; 87:555-561.
6. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84:1020-1023.
7. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30:1054-1058.
8. Heredia A, Gilliam B, Latinovic O, Le N, Bamba D, Devico A, et al. Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro. Antimicrob Agents Chemother 2007; 51:2489-2496.
9. Gilliam BL, Heredia A, Devico A, Le N, Bamba D, Bryant JL, et al. Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment. AIDS 2007; 21:2108-2110.
10. Heredia A, Gilliam B, Devico A, Le N, Bamba D, Flinko R, et al. CCR5 density levels on primary CD4 T cells impact the replication and enfuvirtide susceptibility of R5 HIV-1. AIDS 2007; 21:1317-1322.
11. Heredia A, Amoroso A, Davis C, Le N, Reardon E, Dominique JK, et al. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci U S A 2003; 100:10411-10416.
12. Di Benedetto F, Di Sandro S, De Ruvo N, Masetti M, Montalti R, Romano A, et al. Sirolimus monotherapy in liver transplantation. Transplant Proc 2007; 39:1930-1932.
13. Samonakis DN, Cholongitas E, Triantos CK, Griffiths P, Dhillon AP, Thalheimer U, et al. Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis. J Hepatol 2005; 43:1091-1093.